Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434)
Clinical trial NCT02862457 · COMPLETED
Trial details
- NCT number
- NCT02862457
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-23
- Primary completion
- 2020-11-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.